- Home
- ELAB vs IMCC Comparison
ELAB vs IMCC Comparison
Compare ELAB & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELAB
- IMCC
- Stock Information
- Founded
- ELAB 2020
- IMCC 1980
- Country
- ELAB United States
- IMCC Israel
- Employees
- ELAB N/A
- IMCC N/A
- Industry
- ELAB
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- ELAB
- IMCC Health Care
- Exchange
- ELAB Nasdaq
- IMCC Nasdaq
- Market Cap
- ELAB 6.6M
- IMCC 5.3M
- IPO Year
- ELAB 2023
- IMCC N/A
- Fundamental
- Price
- ELAB $2.17
- IMCC $2.76
- Analyst Decision
- ELAB
- IMCC
- Analyst Count
- ELAB 0
- IMCC 0
- Target Price
- ELAB N/A
- IMCC N/A
- AVG Volume (30 Days)
- ELAB 77.7K
- IMCC 632.5K
- Earning Date
- ELAB 05-14-2025
- IMCC 05-15-2025
- Dividend Yield
- ELAB N/A
- IMCC N/A
- EPS Growth
- ELAB N/A
- IMCC N/A
- EPS
- ELAB N/A
- IMCC N/A
- Revenue
- ELAB N/A
- IMCC $37,894,737.00
- Revenue This Year
- ELAB N/A
- IMCC $47.12
- Revenue Next Year
- ELAB N/A
- IMCC $12.83
- P/E Ratio
- ELAB N/A
- IMCC N/A
- Revenue Growth
- ELAB N/A
- IMCC 12.68
- 52 Week Low
- ELAB $1.95
- IMCC $1.29
- 52 Week High
- ELAB $939.96
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- ELAB 37.11
- IMCC 52.50
- Support Level
- ELAB $2.06
- IMCC $2.55
- Resistance Level
- ELAB $2.23
- IMCC $7.12
- Average True Range (ATR)
- ELAB 0.18
- IMCC 1.08
- MACD
- ELAB 0.05
- IMCC 0.01
- Stochastic Oscillator
- ELAB 29.92
- IMCC 21.85
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.